Zeroing In®: Ending the HIV Epidemic
Gilead's Zeroing In® grant funds community-based HIV education, non-clinical testing, prevention, and digital health solutions to advance the fight against HIV in 47 countries.
Funder: Gilead Sciences
Due Dates (Anticipated): June 2026 (application deadline, projected)
Funding Amounts: Not specified; varies by project and region.
Summary: Supports community-based HIV education, non-clinical testing, prevention, and digital health strategies in 47 countries.
Description
Zeroing In®: Ending the HIV Epidemic is a Gilead Sciences initiative designed to advance community-driven efforts to combat HIV across 47 countries. The program funds projects that expand HIV education and outreach, support innovative non-clinical testing and prevention programs, and leverage digital health strategies to increase access to HIV prevention, testing, and care. The initiative aims to reach people outside traditional healthcare settings and foster innovative, community-based solutions to end the HIV epidemic.
